Monthly Archives: March 2010

The deadline for nominations to the Maryland Incubator Company of the Year Award, which I will be helping judge, has been extended to March 31, 2010.

All Maryland Incubator and Incubator affiliate companies are invited to apply.

The website to apply is http://www.mdincubatoraward.com/2010/2010_nominationform.aspx

More information is at http://www.mdincubatoraward.com

Get to Market Now! Turn FDA Compliance into a Competitive Edge in the Era of Personalized MedicineComing soon, a book by frequent BiotechBlog contributor, John Avellanet. In this new book — Get to Market Now! Turn FDA Compliance into a Competitive Edge in the Era of Personalized Medicine — John teaches you how to take advantage of evolving FDA compliance requirements and cutting-edge new product development techniques to bring your new medicine to market faster, easier, for less cost and less risk.

Full details on the book are available on Logos Press’ website, and the book is available for pre-order at Barnes and Noble. You can read more about John at his homepage and blog.

Media outlets interested in a review copy can contact info@logos-press.com.

I recently gave a talk on educating the next generation of biotechnology managers and founders at a biotechnology education workshop. My sense is that the traditional education paths are not ideal ways to prepare individuals to manage or start biotechnology companies, and I describe cases from Best Practices in Biotechnology Education and courses I have been involved with to illustrate how educational programs can better prepare students for these roles.

I’ve attached a copy of my presentation below.

Drug Patent Expirations in March 2010

*Drugs may be covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
AZASITE Inspire azithromycin 5,192,535 Mar 9, 2010
SOLAGE Stiefel Labs Inc mequinol; tretinoin 5,470,567 Mar 19, 2010
PYLERA Axcan Scandipharm bismuth subcitrate potassium; metronidazole; tetracycline 5,476,669 Mar 23, 2010
KADIAN Actavis Elizabeth morphine sulfate 5,378,474 Mar 23, 2010
PYLERA Axcan Scandipharm bismuth subcitrate potassium; metronidazole; tetracycline 5,196,205 Mar 23, 2010
EMBEDA Alpharma King morphine sulfate; naltrexone hydrochloride 5,378,474 Mar 23, 2010
CADUET Pfizer amlodipine besylate; atorvastatin calcium 4,681,893*PED Mar 24, 2010
LIPITOR Pfizer atorvastatin calcium 4,681,893*PED Mar 24, 2010
CARDENE SR Ekr Therap nicardipine hydrochloride 5,198,226 Mar 30, 2010

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.Courtesy of DrugPatentWatch.com